| Serial Number | 79354136 |
| Word Mark | STELLABODY |
| Filing Date | Thursday, September 8, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 4, 2024 |
| Registration Number | 7404002 |
| Registration Date | Tuesday, June 4, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 19, 2024 |
| Goods and Services | Colostral antibodies for medical purposes; monoclonal antibodies for medical use; monoclonal antibodies for medical diagnostic use; tagged antibodies for medical use; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; monoclonal antibody reagents for medical use; clinical medical reagents for use in the development of monoclonal antibodies; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; immunoassay reagents for medical use; protein arrays for medical use in binding antibodies; protein arrays for medical use in detecting antibodies; biological preparations for pharmaceutical purposes for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions; immunological products, namely, pharmaceutical preparations for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions; pharmaceutical immunoglobulin preparations for treatment of immunological disorders; vaccines; vaccine adjuvants; pharmaceutical products for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions |
| Pseudo Mark | STELLA BODY |
| Goods and Services | Immunological antibodies, other than for medical use; reagents for scientific purposes; diagnostic reagents for scientific use; chemical testing reagents for scientific use; laboratory reagents for scientific use; biochemical preparations for laboratory purposes; immunoassay reagents, other than for medical use; enzymes for scientific purposes; chemical diagnostic reagents for scientific use; recombinant protein being biochemical preparations for scientific use |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | The Macfarlane Burnet Institute for Medical Research and Public Health Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | The Macfarlane Burnet Institute for Medical Research and Public Health Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Party Name | The Macfarlane Burnet Institute for Medical Research and Public Health Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
| Event Date | Event Description |
| Thursday, November 3, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 8, 2022 | APPLICATION FILING RECEIPT MAILED |
| Thursday, June 22, 2023 | ASSIGNED TO EXAMINER |
| Thursday, June 29, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, June 30, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, August 5, 2023 | REFUSAL PROCESSED BY MPU |
| Saturday, August 5, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, August 28, 2023 | REFUSAL PROCESSED BY IB |
| Friday, October 20, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Saturday, February 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, February 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 10, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 28, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, April 3, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 3, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, April 22, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, June 4, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 4, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, September 4, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, November 16, 2024 | GENERIC MADRID TRANSACTION SENT TO IB |
| Saturday, November 16, 2024 | GENERIC MADRID TRANSACTION CREATED |
| Saturday, December 21, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |